DUGiDocsMetformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
Text Complet
Compartir
The development of a single immuno-metabolic adjuvant capable of modulating, in the appropriate direction and intensity, the complex antagonistic and symbiotic interplays between tumor cells, immune cells, and the gut microbiota may appear pharmacologically implausible. Metformin might help solve this conundrum and beneficially impact the state of cancer-immune system interactions
Aquest document està subjecte a una llicència Creative Commons:Reconeixement - No comercial - Sense obra derivada (by-nc-nd)
Ítems relacionats
Mostrant ítems relacionats per títol, autor o matèria
